Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394)

NCT00590785 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

60

Enrollment

NIH

Sponsor class

Conditions

High Risk
Breast Cancer
Positive Nodes
Cyclophosphamide
Doxorubicin

Interventions

DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: G-CSF
DRUG: tamoxifen
DRUG: ciprofloxacin

Sponsor

National Cancer Institute (NCI)

Collaborators

[object Object]